Two cases of alprazolam-induced hyperprolactinemia in patients with panic disorder

International Clinical Psychopharmacology

Volumn 11, Issue 2, 1996, Pages 149-152

  Shioiri, T ^a   Kita, N ^a   Takahashi, S ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

5 HT; Alprazolam; GABA; Hyperprolactinemia; Panic disorder; Side effects

Indexed keywords

ALPRAZOLAM;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; HYPERPROLACTINEMIA; ORAL DRUG ADMINISTRATION; PANIC; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL;

EID: 0029885127     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199611020-00010     Document Type: Article

References (36)

1. APA (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised. American Psychiatric Association, Washington, DC.
2. Apostolopoulos M, Judd FK, Burrows GD et al. (1993) Prolactin response to dl-Fenfluramine in panic disorder. Psychoneuroendocrinology, 18, 337-342.
3. Ballenger JR, Burrows GD, DuPont RL et al. (1988) Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment. Archives of General Psychiatry, 45, 413-422.
4. Beary MD, Lacey JH and Bhat AV (1983) The neuroendcrine impact of 3-hydroxy-diazepam in women. Psychopharmacology, 79, 295-297.
5. Belin MF, Nanopoulos D, Didier M et al. (1983) Immunohistochemical evidence for the presence of gamma-aminobutyric acid and 5-HT in one nerve cell. A study on the raphe nuclei of the rat using antibodies to glutamate decarboxylase and 5-HT. Brain Research, 275, 329-339.
6. Bergman D, Futterweit W, Segal R et al. (1981) Increased oestradiol in diazepam related gynaecomastia. Lancet, 28, 1225-1226.
7. Braestrup C and Nielsen M (1983) Benzodiazepine receptors. In: Handbook of Psychopharmacology (Eds L Iverson, SD Iverson and SM Snyder), pp. 285-384. Plenum Press, New York.
8. Charney DS, Woods SW, Goodman WK et al. (1987) Serotonin function in anxiety. II. Effects of the 5-HT agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology, 92, 14-24.
9. D'Armiento M, Bisignani G and Reda G (1981) Effect of bromazepam on growth hormone and prolactin secretion in normal subjects. Hormone Research, 15, 224-227.
10. Fonnum F (1987) Biochemistry, anatomy, and pharmacology of GABA neurons. In: Psychopharmacology. The Third Generation of Progress (Ed. HY Meltzer), pp. 173-182. Raven Press, New York.
11. Forchetti CM and Meek JL (1981) Evidence for a tonic GABAergic control of 5-HT neurons in the median raphe nucleus. Brain Research, 206, 208-212.
12. George DT, Nutt DJ, Rawlings RR et al. (1995) Behavioral and endocrine response to clomipramine in panic disorder patients with or without alcoholism. Biological Psychiatry, 37, 112-119.
13. Grandison L (1982) Suppression of prolactin secretion by benzodiazepines in vivo. Neuroendocrinology, 34, 369-373.
14. Hyman SE and Arana GW (1987) Antipsychotic drugs. In: Handbook of Psychiatric Drug Therapy (Eds SE Hyman and GW Arana), pp. 4-36. Little, Brown and Company, Boston.
15. Kahn RS and van Praag (1988) A 5-HT hypothesis of panic disorder. Human Psychopharmacology, 3, 285-288.
16. Kahn RS, Weltzler S, Asnis GM et al. (1990) Effects of m-chlorophenylpiperazine in normal subjects: a dose response study. Psychopharmacology, 100, 339-343.
17. Keller HH, Schzffner R and Haefely W (1976) Interaction of benzodiazepines with neuroleptics at central dopamine neurons. Archives of Pharmacology, 294, 1-7.
18. Kimura M (1984) Effects of anti-anxietic drug alprazolam on pituitary hormone. Yakuri to Chiryou, 12, 4281-4288 (in Japanese).
19. Lotz W (1982) Benzodiazepine antagonist Ro 15-1788 counteracts the prolactin-lowering effect of other benzodiazepines in rats. Neuroendocrinology, 35, 32-36.
20. Moerck HJ and Magelund G (1979) Gynaecomastia and diazepam abuse. Lancet, 23, 1344-1345.
21. Nishikawa T and Scatton B (1985a) Involvement of the habenulo-raphe pathways in the GABAergic inhibition of ascending serotonergic neurons. Brain Research, 331, 81-90.
22. Nishikawa T and Scatton B (1985b) Inhibitory influence of GABA on central serotonergic transmission: raphe nuclei as the neuroanatomical site of the GABAergic inhibition of cerebral serotonergic neurons. Brain Research, 331, 91-103.
23. Preziosi P (1983a) Serotonin control of prolactin release: an intriguing puzzle. Trends in Pharmacological Science, 4, 171-174.
24. Preziosi P, Cerrito F and Vacca M (1983b) effects of naloxone on the secretion of prolactin and corticosterone induced by 5-hydroxytryptophan and a serotonergic agonist, m CPP. Life Science, 32, 2423-2430.
25. Racagni G, Apud JA, Cocchi D et al. (1982) GABAergic control of anterior pituitary hormones secretion. Life Science, 31, 823-838.
26. Rastogi RB, Lapierre YD, Radhey LS and Nair NPV (1980) Evidence for involvement of dopamine in the action of diazepam: potentiation of haloperidol and chlorpromazine action in the brain. Advances in Biochemistry and Psychopharmacology, 24, 283-289.
27. Rohrer T, von-Richthofen V, Schulz C, Beyer J and Lehnert H (1994) The stress-, but not corticotropin-releasing hormone-induced activation, of the pituitary-adrenal axis in man is blocked by alprazolam. Hormone and Metabolism Research, 26, 200-206.
28. Rubin RT (1987) Prolactin and schizophrenia. In: Psychopharmacology. The Third Generation of Progress (Ed. HY Meltzer), pp. 803-808. Raven Press, New York.
29. Singhal RL, Rastogi RB and Lapierre YD (1983) Diazepam potentiates the effect of neuroleptics on behavioral activity as well as dopamine and norepinephrine turnover: do benzodiazepines have antipsychotic potency? Journal of Neural Transmission, 56, 127-138.
30. Sowa M, Minami S and Nakano R (1989) Basic and clinical studies on immunoradiometric assay (SPAC-S prolactin kit) for measurement of serum prolactin. Clinical Endocrinology, 37, 867-872 (in Japanese).
31. Tagrum SD and Marshall LE (1989) Fenfluramine provocation of anxiety in patients with panic disorder. Psychiatry Research, 28, 295-306.
32. Tagrum SD (1990) Differential responses to anxiogenic challenge studies in patients with major depressive disorder and panic disorder. Biological Psychiatry, 28, 21-34.
33. Takahashi J (1981) Mechanism of prolactin release by 5-hydroxytryptophan. Life Science, 26, 1463-1466.
34. Van Kammen DP (1977) Gamma-aminobutyric acid (GABA) hypothesis of schizophrenia. American Journal of Psychiatry, 134, 138-143.
35. Waszczak B and Walters J (1979) Effects of GABA mimetics on substantia nigra neurons. Advances in Neurology, 23, 727-740.
36. Zemishlany Z, McQueeney R, Gabriel SM et al. (1990) Neuroendcrine and monoaminergic responses to acute administration of alprazolam in normal subjects. Neuropsychobiology, 23, 124-128.